PALI
Palisade BioCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
PALI vs peer average
59/100
PALI vs. peer average (C vs. D)
Grade spread
A 1 · B 2 · C 2 · D 2 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
RLMD is the first available peer comparator.
Clinical-stage small-cap biotech with binary program catalysts and financing sensitivity; useful comparator for how pre-proof-of-concept drug developers rerate around trial updates.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PALI
Palisade Bio
RLMD
Relmada Therapeutics
Grade
C
D
Momentum
85
5
Value
41
41
Sentiment
59
64
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs RLMD
PALI / RLMD
Grade Position
In line
PALI vs. peer average (C vs. D)
59/100
Momentum
85
PALIValue
41
PALISentiment
59
RLMDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PALI
RLMD is the first peer returned for this comparison set.